Lifecome Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 14, 2022 at 08:37 am
Share
Lifecome Biochemistry Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 62.69 million compared to CNY 90.93 million a year ago. Revenue was CNY 62.69 million compared to CNY 90.93 million a year ago. Net loss was CNY 8.91 million compared to net income of CNY 2.4 million a year ago. Basic loss per share from continuing operations was CNY 0.06 compared to basic earnings per share from continuing operations of CNY 0.02 a year ago. Diluted loss per share from continuing operations was CNY 0.06 compared to diluted earnings per share from continuing operations of CNY 0.02 a year ago.
LIFECOME BIOCHEMISTRY CO LTD is a China-based company principally engaged in the development, production and sales of veterinary drugs. The Company's businesses include the production and sales of veterinary premixes, veterinary raw materials, veterinary soluble powders, food additives, feed additives and biological pesticide. Its products include bacitracin products, colistin sulfate products, flavomycin products, natamycin, Bacillus subtilis, Bacillus licheniformis, mixed probiotics, Bacillus thuringiensis series and Jinggangmycin series. The Company distributes its products within domestic market and to overseas markets.